Burnie Academy Academy
GLP-1 with insulin: the low-blood-sugar risk

GLP-1 with insulin: the low-blood-sugar risk

GLP-1 medicines alone rarely cause low blood sugar. But add insulin, and the danger goes up. Your doctor can lower the insulin dose to keep you safe.

13 Jul 2026 · Burnie Academy
glp-1 insulin hypoglycemia low-blood-sugar

You take a GLP-1 medicine like semaglutide or tirzepatide. You also take insulin for diabetes. Both lower your blood sugar. Together, they can lower it too much. That is called hypoglycemia, or a 'low.' It can make you shaky and confused. The good news: your doctor can adjust your doses to keep you safe. This short guide explains how, in plain words.

Why two sugar-lowering medicines raise the risk

GLP-1 medicines lower blood glucose, but on their own they do it gently. The risk of a dangerous low is small. Insulin also lowers blood glucose, and it is strong. When you mix the two, the effects add up. Your sugar can drop faster and lower than with either one alone. The drug labels say this clearly. The Wegovy label warns: 'Patients with diabetes mellitus taking WEGOVY in combination with insulin or an insulin secretagogue may have an increased risk of hypoglycemia, including severe hypoglycemia.' An insulin secretagogue is a pill that pushes your body to make more insulin, like a sulfonylurea. So insulin and sulfonylurea pills both count here.

GLP-1 medicines by themselves often cause low blood sugar.

mostly false

Mostly false. On their own, GLP-1 receptor agonists have a low risk of hypoglycemia. The Mounjaro (tirzepatide) label reports that in monotherapy trials, hypoglycemia (blood glucose below 54 mg/dL) happened in 0% of patients on the medicine versus 1% on placebo, with no severe hypoglycemia. The risk climbs mainly when you add insulin or a sulfonylurea. So the danger is the mix, not the GLP-1 alone.

GLP-1 alone vs GLP-1 with insulin

GLP-1 alone
Low risk of low blood sugar. The Mounjaro label shows 0% severe lows when used without insulin or sulfonylurea.
GLP-1 + insulin
Higher risk. Both medicines lower sugar, so lows can happen more often and be more severe.
GLP-1 + sulfonylurea pill
Also higher risk. A sulfonylurea pushes your body to make extra insulin, so the effect stacks.
What the label advises
The Ozempic label says: 'When initiating OZEMPIC, consider reducing the dose of concomitantly administered insulin secretagogue (such as sulfonylureas) or insulin to reduce the risk of hypoglycemia.'

The bottom line

GLP-1 medicines alone rarely cause low blood sugar. The risk jumps when you add insulin or a sulfonylurea, because both lower glucose. Your doctor may lower your insulin dose when you start the GLP-1, and again as your weight and insulin resistance improve. Check your sugar, know the shaky-sweaty-confused signs, and always carry a fast sugar. Never change doses on your own. Talk to your doctor first.

Track your food the honest way

Burnie helps you see your estimated calorie deficit with familiar Indian foods — no fake precision, no guilt trips.

Get Burnie on the App Store

Android public availability is being expanded.